title: Gene therapy to develop a genetically engineered cardiac pacemaker.
abstract: While cardiac pacemakers are frequently used for the treatment of bradydysrhythmias (from diseases of the cardiac conduction system), their use is still limited by complications that can be life-threatening and expensive. Genetic engineering approaches offer an opportunity to modulate cellular automaticity in a manner that could have significant therapeutic potential. It is well known that ventricular myocytes exhibit a more negative diastolic potential than do pacemaker cells, in large part because of the inward rectifying potassium current/K1 (which pacemaker cells lack). Taking advantage of these intrinsic electrophysiological differences, a biological pacemaker has recently been developed by Miake et al (Nature 2002; 419:132-133) using adenoviral gene transfer approaches. By isolating the gene responsible for/K1 (the Kir2.1 gene), mutating it to make it a dysfunctional channel (a dominant-negative), inserting the mutated gene into an adenoviral vector, and delivering the virus to the hearts of guinea pigs, the investigators were able to successfully convert some ventricular myocytes to pacemaker cells. While issues of safety and long-term efficacy need to be further established, the results of these experiments provide proof of principle that gene transfer offers great promise for treatment of electrophysiological disorders including conduction system disease.
authors.affiliation: Department of Medicine, University of Illinois at Chicago, Chicago, Ill 60612, USA.
authors.forename: Christopher M
authors.initials: CM
authors.lastname: Glenn
authors.forename: Steven M
authors.initials: SM
authors.lastname: Pogwizd
mesh_terms: D000200:Action Potentials / Q000235:genetics; D001145:Arrhythmias, Cardiac / Q000628:therapy; D004867:Equipment Design; D018014:Gene Transfer Techniques; D005818:Genetic Engineering / Q000379:methods; D015316:Genetic Therapy; D006329:Heart Conduction System / Q000166:cytology / Q000503:physiopathology / Q000601:surgery; D006352:Heart Ventricles / Q000166:cytology / Q000503:physiopathology / Q000601:surgery; D006801:Humans; D015994:Incidence; D032383:Myocytes, Cardiac / Q000502:physiology; D010138:Pacemaker, Artificial; D014481:United States / Q000453:epidemiology